Détention brevets de la classe A61K 31/5395

Brevets de cette classe: 179

Historique des publications depuis 10 ans

10
15
8
13
12
17
9
13
5
6
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
Bow River LLC
22
15
Bayer AG
3362
8
The Broad Institute, Inc.
1851
8
Principia Biopharma Inc.
236
7
The Regents of the University of California
20153
6
Dana-Farber Cancer Institute, Inc.
2602
5
Abbvie Inc.
1800
4
Eli Lilly and Company
3898
4
BASF SE
21036
3
Bayer Pharma AG
1054
3
Dechra Veterinary Products LLC
91
3
The United States of America, as represented by the Secretary, Department of Health and Human Services
2886
3
USpharma Ltd.
18
3
Merck Sharp & Dohme LLC
3737
3
Zevra Denmark A/S
55
3
Merck Sharp & Dohme Corp.
2190
2
Abbott Products GmbH
9
2
University of Florida Research Foundation, Inc.
4055
2
Asahi Kasei Pharma Corporation
131
2
CytRx Corporation
13
2
Autres propriétaires 91